Pulmonary CME Courses

Pulmonary CME Courses

Format: Online Streaming Video
Price: Free
Release Date: May 9, 2016
Expiration Date: May 9, 2018
Summary:

By the end of the session the participant will be able to:

  • Describe the impact of biomarker and mutation testing and their results for the management of patients with NSCLC and apply this knowledge to patient cases.
  • Describe the role and impact of the initial biopsy, including the relevance of its timing and factors affecting quality of results.
  • Distinguish between different NSCLC disease subtypes on the basis of histology, biomarker, and mutation status and use the information to optimize care in the setting of patient cases.
  • Discuss the ways that NSCLC has proved resistant to treatments in past and the mechanisms of action of targeted therapies, present and emerging
  • Determine how to incorporate the following components into a NSCLC treatment regimen in a manner that optimizes efficacy, safety, and tolerability: sequencing, dose reduction, and biomarker and mutation status testing


Share This